Comparison of glucose variability assessed by a continuous glucose-monitoring system in patients with type 2 diabetes mellitus switched from NPH ... View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2014-04

AUTHORS

Denisa Janickova Zdarska, Milan Kvapil, Zdenek Rusavy, Michal Krcma, Jan Broz, Bohumila Krivska, Pavla Kadlecova

ABSTRACT

BACKGROUND: Glucose variability combined with glycosylated hemoglobin (HbA1c) assessments more reliably represents the level of glycemic control. The study was aimed to compare blood glucose variability with insulin glargine vs. neutral protamine Hagedorn (NPH) in patients with type 2 diabetes mellitus using a continuous glucose-monitoring system (CGMS), in patients treated with basal insulin using stable dose of oral antidiabetic agents and HbA1c in the range of 4.5-8.0 % International Federation of Clinical Chemistry (IFCC) units. [6.2-9.4 % Diabetes Control and Complications Trial (DCCT) units]. METHODS: This was a multicenter, prospective, open-label, single-arm study in patients (N = 116) treated for ≥ 2 months with NPH and metformin combined with sulfonylurea or glinide. Glucose variability was measured after a 4-week NPH treatment phase and after a subsequent 12-week glargine treatment phase using CGMS. Based on 72-hour CGMS, glucose variability was assessed by area under the curve [AUC (mmol/L · h)]. Differences (glargine-NPH) in AUC within 24 h in the glucose ranges of ≤ 3.3, ≤ 3.9, 7.5-3.9 (margins excluding), ≥ 7.5, ≥ 10, and ≥ 15 mmol/L were evaluated. Circadian fluctuation of glucose was assessed by M-value (log-transformation of the deviation from an arbitrary standard). RESULTS: AUCs of glucose in the lowest ranges (≤ 3.3 and ≤ 3.9 mmol/L) did not change significantly after treatment with glargine. Those in the higher ranges (≥ 7.5, ≥ 10, and ≥ 15 mmol/L) were significantly lower (p < 0.001 for all ranges), whereas AUC of glucose in the normal range (3.9-7.5 mmol/L) was significantly higher (p < 0.001) at the end of glargine treatment phase. Circadian fluctuation of glucose assessed by M-value showed a significant decrease after glargine treatment (p < 0.003). No significant differences in hypoglycemia confirmed by glucose value ≤ 3.3 mmol/L were found between treatment phases. This trial is registered at ClinicalTrials.gov, NCT00659477. CONCLUSIONS: As monitored by CGMS, switching from NPH to glargine with active titration shifted glucose from abnormally high to normal levels with reduced fluctuation and without increased risk of hypoglycemia. More... »

PAGES

228-237

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00508-014-0508-6

DOI

http://dx.doi.org/10.1007/s00508-014-0508-6

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1032371172

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/24563017


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adolescent", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged, 80 and over", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Blood Glucose", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Czech Republic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Diabetes Mellitus, Type 2", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Monitoring", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Substitution", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hypoglycemic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Insulin Glargine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Insulin, Isophane", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Insulin, Long-Acting", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Reproducibility of Results", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Sensitivity and Specificity", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Young Adult", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Charles University", 
          "id": "https://www.grid.ac/institutes/grid.4491.8", 
          "name": [
            "Medical Department, Second Faculty of Medicine, Charles University, Prague, Czech Republic"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zdarska", 
        "givenName": "Denisa Janickova", 
        "id": "sg:person.01170432366.10", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01170432366.10"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Charles University", 
          "id": "https://www.grid.ac/institutes/grid.4491.8", 
          "name": [
            "Medical Department, Second Faculty of Medicine, Charles University, Prague, Czech Republic"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kvapil", 
        "givenName": "Milan", 
        "id": "sg:person.01302051742.38", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01302051742.38"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Charles University", 
          "id": "https://www.grid.ac/institutes/grid.4491.8", 
          "name": [
            "Medical Department, University Hospital and Medical Faculty, Charles University, Plzen, Czech Republic"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rusavy", 
        "givenName": "Zdenek", 
        "id": "sg:person.01150515406.56", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01150515406.56"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Charles University", 
          "id": "https://www.grid.ac/institutes/grid.4491.8", 
          "name": [
            "Medical Department, University Hospital and Medical Faculty, Charles University, Plzen, Czech Republic"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Krcma", 
        "givenName": "Michal", 
        "id": "sg:person.01252310256.87", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01252310256.87"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Charles University", 
          "id": "https://www.grid.ac/institutes/grid.4491.8", 
          "name": [
            "Medical Department, Second Faculty of Medicine, Charles University, Prague, Czech Republic"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Broz", 
        "givenName": "Jan", 
        "id": "sg:person.01143104532.00", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01143104532.00"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Sanofi (Czechia)", 
          "id": "https://www.grid.ac/institutes/grid.486745.c", 
          "name": [
            "Sanofi-Aventis, Prague, Czech Republic"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Krivska", 
        "givenName": "Bohumila", 
        "id": "sg:person.0741007442.93", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0741007442.93"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "ADDS, Brno, Czech Republic"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kadlecova", 
        "givenName": "Pavla", 
        "id": "sg:person.01163067701.72", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01163067701.72"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1067/mlc.2003.27", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000279195"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1067/mlc.2003.27", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000279195"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/diabetes.49.12.2142", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012893424"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(98)07019-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018881858"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/dmrr.962", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020788873"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/dmrr.962", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020788873"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1191/1358863x05vm617oa", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022598259"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1191/1358863x05vm617oa", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022598259"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1191/1358863x05vm617oa", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022598259"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/dmrr.865", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029438858"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/diabetes.52.11.2795", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031896781"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ahj.2005.09.015", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038297492"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1464-5491.2010.03059.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041250716"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1464-5491.2010.03059.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041250716"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jdiacomp.2004.10.001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043684517"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/dc07-2401", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046271441"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/diacare.23.8.1130", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050330235"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s001250050617", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050926721", 
          "https://doi.org/10.1007/s001250050617"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s001250050617", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050926721", 
          "https://doi.org/10.1007/s001250050617"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/diacare.23.6.813", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052130317"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/01.hjr.0000368193.24732.66", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1060330355"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/01.hjr.0000368193.24732.66", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1060330355"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/9780470316771", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1106811650"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2014-04", 
    "datePublishedReg": "2014-04-01", 
    "description": "BACKGROUND: Glucose variability combined with glycosylated hemoglobin (HbA1c) assessments more reliably represents the level of glycemic control. The study was aimed to compare blood glucose variability with insulin glargine vs. neutral protamine Hagedorn (NPH) in patients with type 2 diabetes mellitus using a continuous glucose-monitoring system (CGMS), in patients treated with basal insulin using stable dose of oral antidiabetic agents and HbA1c in the range of 4.5-8.0\u2009% International Federation of Clinical Chemistry (IFCC) units. [6.2-9.4\u2009% Diabetes Control and Complications Trial (DCCT) units].\nMETHODS: This was a multicenter, prospective, open-label, single-arm study in patients (N\u2009=\u2009116) treated for \u2265\u20092 months with NPH and metformin combined with sulfonylurea or glinide. Glucose variability was measured after a 4-week NPH treatment phase and after a subsequent 12-week glargine treatment phase using CGMS. Based on 72-hour CGMS, glucose variability was assessed by area under the curve [AUC (mmol/L\u2009\u00b7\u2009h)]. Differences (glargine-NPH) in AUC within 24 h in the glucose ranges of \u2264\u20093.3, \u2264\u20093.9, 7.5-3.9 (margins excluding), \u2265\u20097.5, \u2265\u200910, and \u2265\u200915 mmol/L were evaluated. Circadian fluctuation of glucose was assessed by M-value (log-transformation of the deviation from an arbitrary standard).\nRESULTS: AUCs of glucose in the lowest ranges (\u2264\u20093.3 and \u2264\u20093.9 mmol/L) did not change significantly after treatment with glargine. Those in the higher ranges (\u2265\u20097.5, \u2265\u200910, and \u2265\u200915 mmol/L) were significantly lower (p\u2009<\u20090.001 for all ranges), whereas AUC of glucose in the normal range (3.9-7.5 mmol/L) was significantly higher (p\u2009<\u20090.001) at the end of glargine treatment phase. Circadian fluctuation of glucose assessed by M-value showed a significant decrease after glargine treatment (p\u2009<\u20090.003). No significant differences in hypoglycemia confirmed by glucose value \u2264\u20093.3 mmol/L were found between treatment phases. This trial is registered at ClinicalTrials.gov, NCT00659477.\nCONCLUSIONS: As monitored by CGMS, switching from NPH to glargine with active titration shifted glucose from abnormally high to normal levels with reduced fluctuation and without increased risk of hypoglycemia.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s00508-014-0508-6", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1070586", 
        "issn": [
          "1026-4906", 
          "1563-2571"
        ], 
        "name": "Wiener klinische Wochenschrift", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "7-8", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "126"
      }
    ], 
    "name": "Comparison of glucose variability assessed by a continuous glucose-monitoring system in patients with type 2 diabetes mellitus switched from NPH insulin to insulin glargine: The COBIN2 study", 
    "pagination": "228-237", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "9a364240f98063b976b42b2192d371c55e07536da1e4338c80b46b7a1a3d35d6"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "24563017"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "21620870R"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00508-014-0508-6"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1032371172"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00508-014-0508-6", 
      "https://app.dimensions.ai/details/publication/pub.1032371172"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T21:51", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8687_00000589.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007/s00508-014-0508-6"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00508-014-0508-6'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00508-014-0508-6'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00508-014-0508-6'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00508-014-0508-6'


 

This table displays all metadata directly associated to this object as RDF triples.

250 TRIPLES      21 PREDICATES      66 URIs      42 LITERALS      30 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00508-014-0508-6 schema:about N00d25c92f3324b5aba0ee80ca3f6996a
2 N0d32b80117e847ed89d79e704afa29a9
3 N0eda4486e2a145d6984781e9de376095
4 N1aac95e8a3ae4d65857feaa2f566096a
5 N2615f71fcc484708967e0f8945ccc756
6 N3527dbaf0dbe45f8a530a1449b0ce751
7 N3f8a4e1bf2df48cfb8debad6545e42b7
8 N50bc40172409425d954f17be5d2ab43a
9 N5dab7a5c969c4a0b911cd4746f1d3c5a
10 N648c4b3d5ce341b29ab0dca38c796727
11 N6b888651301c4d04a9993c3739369e80
12 N741fb50a0a04479b912df4f984ea51a7
13 N80aeb527a85c4d6ba57ee7b6463ba698
14 N880f784f979e4b2cab3cb8f4f72eb848
15 N8be79c40ecfc4a6199f856885bb57962
16 Na8c176db09a24c30a7d81757377b1b8a
17 Naaf68e80495d48cf940a82725b4e173c
18 Nc1b6eafe8b624abaa3277dddfa69d9e9
19 Nc48b678f3a5f4230b72f4e2eeee3ec3a
20 Ne4113ebcfb1d4191a332c83a92f024db
21 Nf1eaa2cce48d484185630b1dfe31c7b7
22 anzsrc-for:11
23 anzsrc-for:1103
24 schema:author Nbccf99548db2457a9aa4bbff2a0157bd
25 schema:citation sg:pub.10.1007/s001250050617
26 https://doi.org/10.1002/9780470316771
27 https://doi.org/10.1002/dmrr.865
28 https://doi.org/10.1002/dmrr.962
29 https://doi.org/10.1016/j.ahj.2005.09.015
30 https://doi.org/10.1016/j.jdiacomp.2004.10.001
31 https://doi.org/10.1016/s0140-6736(98)07019-6
32 https://doi.org/10.1067/mlc.2003.27
33 https://doi.org/10.1097/01.hjr.0000368193.24732.66
34 https://doi.org/10.1111/j.1464-5491.2010.03059.x
35 https://doi.org/10.1191/1358863x05vm617oa
36 https://doi.org/10.2337/dc07-2401
37 https://doi.org/10.2337/diabetes.49.12.2142
38 https://doi.org/10.2337/diabetes.52.11.2795
39 https://doi.org/10.2337/diacare.23.6.813
40 https://doi.org/10.2337/diacare.23.8.1130
41 schema:datePublished 2014-04
42 schema:datePublishedReg 2014-04-01
43 schema:description BACKGROUND: Glucose variability combined with glycosylated hemoglobin (HbA1c) assessments more reliably represents the level of glycemic control. The study was aimed to compare blood glucose variability with insulin glargine vs. neutral protamine Hagedorn (NPH) in patients with type 2 diabetes mellitus using a continuous glucose-monitoring system (CGMS), in patients treated with basal insulin using stable dose of oral antidiabetic agents and HbA1c in the range of 4.5-8.0 % International Federation of Clinical Chemistry (IFCC) units. [6.2-9.4 % Diabetes Control and Complications Trial (DCCT) units]. METHODS: This was a multicenter, prospective, open-label, single-arm study in patients (N = 116) treated for ≥ 2 months with NPH and metformin combined with sulfonylurea or glinide. Glucose variability was measured after a 4-week NPH treatment phase and after a subsequent 12-week glargine treatment phase using CGMS. Based on 72-hour CGMS, glucose variability was assessed by area under the curve [AUC (mmol/L · h)]. Differences (glargine-NPH) in AUC within 24 h in the glucose ranges of ≤ 3.3, ≤ 3.9, 7.5-3.9 (margins excluding), ≥ 7.5, ≥ 10, and ≥ 15 mmol/L were evaluated. Circadian fluctuation of glucose was assessed by M-value (log-transformation of the deviation from an arbitrary standard). RESULTS: AUCs of glucose in the lowest ranges (≤ 3.3 and ≤ 3.9 mmol/L) did not change significantly after treatment with glargine. Those in the higher ranges (≥ 7.5, ≥ 10, and ≥ 15 mmol/L) were significantly lower (p < 0.001 for all ranges), whereas AUC of glucose in the normal range (3.9-7.5 mmol/L) was significantly higher (p < 0.001) at the end of glargine treatment phase. Circadian fluctuation of glucose assessed by M-value showed a significant decrease after glargine treatment (p < 0.003). No significant differences in hypoglycemia confirmed by glucose value ≤ 3.3 mmol/L were found between treatment phases. This trial is registered at ClinicalTrials.gov, NCT00659477. CONCLUSIONS: As monitored by CGMS, switching from NPH to glargine with active titration shifted glucose from abnormally high to normal levels with reduced fluctuation and without increased risk of hypoglycemia.
44 schema:genre research_article
45 schema:inLanguage en
46 schema:isAccessibleForFree false
47 schema:isPartOf N8c9207865e684ea3b603a0fcf3bf46bb
48 Naa47df585c88423abdabe1e95b71a857
49 sg:journal.1070586
50 schema:name Comparison of glucose variability assessed by a continuous glucose-monitoring system in patients with type 2 diabetes mellitus switched from NPH insulin to insulin glargine: The COBIN2 study
51 schema:pagination 228-237
52 schema:productId N0618829916c04d8e9dfcd1848501ec60
53 N3f98961c5b3a4315b324eeca399c81f2
54 N8fe3f186e8b94dec800db2b49c6c98e3
55 Nca74a1dca8614b73a4096bd22a88122f
56 Ndd974e3d3f78414e9e4cf1b4d1871fde
57 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032371172
58 https://doi.org/10.1007/s00508-014-0508-6
59 schema:sdDatePublished 2019-04-10T21:51
60 schema:sdLicense https://scigraph.springernature.com/explorer/license/
61 schema:sdPublisher N69598ac3ebdc410f94de9e1fbdcb3b0c
62 schema:url http://link.springer.com/10.1007/s00508-014-0508-6
63 sgo:license sg:explorer/license/
64 sgo:sdDataset articles
65 rdf:type schema:ScholarlyArticle
66 N00d25c92f3324b5aba0ee80ca3f6996a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
67 schema:name Aged, 80 and over
68 rdf:type schema:DefinedTerm
69 N0618829916c04d8e9dfcd1848501ec60 schema:name doi
70 schema:value 10.1007/s00508-014-0508-6
71 rdf:type schema:PropertyValue
72 N0753c7165fcd4b81bd4ebd29e976c615 rdf:first sg:person.01163067701.72
73 rdf:rest rdf:nil
74 N0d32b80117e847ed89d79e704afa29a9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
75 schema:name Reproducibility of Results
76 rdf:type schema:DefinedTerm
77 N0eda4486e2a145d6984781e9de376095 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
78 schema:name Young Adult
79 rdf:type schema:DefinedTerm
80 N16e824c521584c488c3d8f4957aaa70d rdf:first sg:person.0741007442.93
81 rdf:rest N0753c7165fcd4b81bd4ebd29e976c615
82 N1aac95e8a3ae4d65857feaa2f566096a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
83 schema:name Aged
84 rdf:type schema:DefinedTerm
85 N2615f71fcc484708967e0f8945ccc756 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
86 schema:name Adolescent
87 rdf:type schema:DefinedTerm
88 N2b406a827ec24f30aba27625b62444b8 rdf:first sg:person.01143104532.00
89 rdf:rest N16e824c521584c488c3d8f4957aaa70d
90 N3527dbaf0dbe45f8a530a1449b0ce751 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
91 schema:name Male
92 rdf:type schema:DefinedTerm
93 N3f8a4e1bf2df48cfb8debad6545e42b7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
94 schema:name Insulin, Long-Acting
95 rdf:type schema:DefinedTerm
96 N3f98961c5b3a4315b324eeca399c81f2 schema:name readcube_id
97 schema:value 9a364240f98063b976b42b2192d371c55e07536da1e4338c80b46b7a1a3d35d6
98 rdf:type schema:PropertyValue
99 N4fdca5a7185f4654bc384cc13791623d rdf:first sg:person.01302051742.38
100 rdf:rest N848e85d1d49d4891b865dbff30996e35
101 N50bc40172409425d954f17be5d2ab43a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
102 schema:name Insulin Glargine
103 rdf:type schema:DefinedTerm
104 N5dab7a5c969c4a0b911cd4746f1d3c5a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
105 schema:name Middle Aged
106 rdf:type schema:DefinedTerm
107 N648c4b3d5ce341b29ab0dca38c796727 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
108 schema:name Female
109 rdf:type schema:DefinedTerm
110 N69598ac3ebdc410f94de9e1fbdcb3b0c schema:name Springer Nature - SN SciGraph project
111 rdf:type schema:Organization
112 N6b888651301c4d04a9993c3739369e80 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
113 schema:name Blood Glucose
114 rdf:type schema:DefinedTerm
115 N741fb50a0a04479b912df4f984ea51a7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
116 schema:name Adult
117 rdf:type schema:DefinedTerm
118 N80aeb527a85c4d6ba57ee7b6463ba698 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
119 schema:name Drug Monitoring
120 rdf:type schema:DefinedTerm
121 N848e85d1d49d4891b865dbff30996e35 rdf:first sg:person.01150515406.56
122 rdf:rest Nb463f92735ef48638d7d2bf69f5c6002
123 N880f784f979e4b2cab3cb8f4f72eb848 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Humans
125 rdf:type schema:DefinedTerm
126 N8be79c40ecfc4a6199f856885bb57962 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
127 schema:name Diabetes Mellitus, Type 2
128 rdf:type schema:DefinedTerm
129 N8c9207865e684ea3b603a0fcf3bf46bb schema:issueNumber 7-8
130 rdf:type schema:PublicationIssue
131 N8fe3f186e8b94dec800db2b49c6c98e3 schema:name pubmed_id
132 schema:value 24563017
133 rdf:type schema:PropertyValue
134 Na8c176db09a24c30a7d81757377b1b8a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
135 schema:name Hypoglycemic Agents
136 rdf:type schema:DefinedTerm
137 Naa47df585c88423abdabe1e95b71a857 schema:volumeNumber 126
138 rdf:type schema:PublicationVolume
139 Naaf68e80495d48cf940a82725b4e173c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
140 schema:name Czech Republic
141 rdf:type schema:DefinedTerm
142 Nb463f92735ef48638d7d2bf69f5c6002 rdf:first sg:person.01252310256.87
143 rdf:rest N2b406a827ec24f30aba27625b62444b8
144 Nbccf99548db2457a9aa4bbff2a0157bd rdf:first sg:person.01170432366.10
145 rdf:rest N4fdca5a7185f4654bc384cc13791623d
146 Nc1b6eafe8b624abaa3277dddfa69d9e9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Treatment Outcome
148 rdf:type schema:DefinedTerm
149 Nc48b678f3a5f4230b72f4e2eeee3ec3a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name Drug Substitution
151 rdf:type schema:DefinedTerm
152 Nc4975c3dc5654189ae48fa8c21d4f26f schema:name ADDS, Brno, Czech Republic
153 rdf:type schema:Organization
154 Nca74a1dca8614b73a4096bd22a88122f schema:name dimensions_id
155 schema:value pub.1032371172
156 rdf:type schema:PropertyValue
157 Ndd974e3d3f78414e9e4cf1b4d1871fde schema:name nlm_unique_id
158 schema:value 21620870R
159 rdf:type schema:PropertyValue
160 Ne4113ebcfb1d4191a332c83a92f024db schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
161 schema:name Insulin, Isophane
162 rdf:type schema:DefinedTerm
163 Nf1eaa2cce48d484185630b1dfe31c7b7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
164 schema:name Sensitivity and Specificity
165 rdf:type schema:DefinedTerm
166 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
167 schema:name Medical and Health Sciences
168 rdf:type schema:DefinedTerm
169 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
170 schema:name Clinical Sciences
171 rdf:type schema:DefinedTerm
172 sg:journal.1070586 schema:issn 1026-4906
173 1563-2571
174 schema:name Wiener klinische Wochenschrift
175 rdf:type schema:Periodical
176 sg:person.01143104532.00 schema:affiliation https://www.grid.ac/institutes/grid.4491.8
177 schema:familyName Broz
178 schema:givenName Jan
179 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01143104532.00
180 rdf:type schema:Person
181 sg:person.01150515406.56 schema:affiliation https://www.grid.ac/institutes/grid.4491.8
182 schema:familyName Rusavy
183 schema:givenName Zdenek
184 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01150515406.56
185 rdf:type schema:Person
186 sg:person.01163067701.72 schema:affiliation Nc4975c3dc5654189ae48fa8c21d4f26f
187 schema:familyName Kadlecova
188 schema:givenName Pavla
189 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01163067701.72
190 rdf:type schema:Person
191 sg:person.01170432366.10 schema:affiliation https://www.grid.ac/institutes/grid.4491.8
192 schema:familyName Zdarska
193 schema:givenName Denisa Janickova
194 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01170432366.10
195 rdf:type schema:Person
196 sg:person.01252310256.87 schema:affiliation https://www.grid.ac/institutes/grid.4491.8
197 schema:familyName Krcma
198 schema:givenName Michal
199 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01252310256.87
200 rdf:type schema:Person
201 sg:person.01302051742.38 schema:affiliation https://www.grid.ac/institutes/grid.4491.8
202 schema:familyName Kvapil
203 schema:givenName Milan
204 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01302051742.38
205 rdf:type schema:Person
206 sg:person.0741007442.93 schema:affiliation https://www.grid.ac/institutes/grid.486745.c
207 schema:familyName Krivska
208 schema:givenName Bohumila
209 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0741007442.93
210 rdf:type schema:Person
211 sg:pub.10.1007/s001250050617 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050926721
212 https://doi.org/10.1007/s001250050617
213 rdf:type schema:CreativeWork
214 https://doi.org/10.1002/9780470316771 schema:sameAs https://app.dimensions.ai/details/publication/pub.1106811650
215 rdf:type schema:CreativeWork
216 https://doi.org/10.1002/dmrr.865 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029438858
217 rdf:type schema:CreativeWork
218 https://doi.org/10.1002/dmrr.962 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020788873
219 rdf:type schema:CreativeWork
220 https://doi.org/10.1016/j.ahj.2005.09.015 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038297492
221 rdf:type schema:CreativeWork
222 https://doi.org/10.1016/j.jdiacomp.2004.10.001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043684517
223 rdf:type schema:CreativeWork
224 https://doi.org/10.1016/s0140-6736(98)07019-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018881858
225 rdf:type schema:CreativeWork
226 https://doi.org/10.1067/mlc.2003.27 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000279195
227 rdf:type schema:CreativeWork
228 https://doi.org/10.1097/01.hjr.0000368193.24732.66 schema:sameAs https://app.dimensions.ai/details/publication/pub.1060330355
229 rdf:type schema:CreativeWork
230 https://doi.org/10.1111/j.1464-5491.2010.03059.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1041250716
231 rdf:type schema:CreativeWork
232 https://doi.org/10.1191/1358863x05vm617oa schema:sameAs https://app.dimensions.ai/details/publication/pub.1022598259
233 rdf:type schema:CreativeWork
234 https://doi.org/10.2337/dc07-2401 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046271441
235 rdf:type schema:CreativeWork
236 https://doi.org/10.2337/diabetes.49.12.2142 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012893424
237 rdf:type schema:CreativeWork
238 https://doi.org/10.2337/diabetes.52.11.2795 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031896781
239 rdf:type schema:CreativeWork
240 https://doi.org/10.2337/diacare.23.6.813 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052130317
241 rdf:type schema:CreativeWork
242 https://doi.org/10.2337/diacare.23.8.1130 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050330235
243 rdf:type schema:CreativeWork
244 https://www.grid.ac/institutes/grid.4491.8 schema:alternateName Charles University
245 schema:name Medical Department, Second Faculty of Medicine, Charles University, Prague, Czech Republic
246 Medical Department, University Hospital and Medical Faculty, Charles University, Plzen, Czech Republic
247 rdf:type schema:Organization
248 https://www.grid.ac/institutes/grid.486745.c schema:alternateName Sanofi (Czechia)
249 schema:name Sanofi-Aventis, Prague, Czech Republic
250 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...